Real-World Analysis of Clinical and Demographic Characteristics, Treatment Patterns, and Outcomes in Predominantly Older Patients with HR+/HER2− Metastatic Breast Cancer Receiving Abemaciclib in Routine Clinical Practice

• প্রধান লেখক: Alistair Ring (লেখক), Meghan Karuturi (লেখক), Emily Nash Smyth (লেখক), Tasneem Lokhandwala (লেখক), Kristin M. Sheffield (লেখক), Joanne Willey (লেখক), Orsolya Lunacsek (লেখক), Francisco Sapunar (লেখক), Zhanglin Lin Cui (লেখক), Anna D. Coutinho (লেখক), Sarah Rybowski (লেখক)
• বিন্যাস: গ্রন্থ
• প্রকাশিত: Adis, Springer Healthcare, 2023-09-01T00:00:00Z.
• বিষয়গুলি: article
• অনলাইন ব্যবহার করুন: Connect to this object online.

Abstract Introduction Hormone receptor-positive (HR+)/human epidermal growth factor receptor 2-negative (HER2−) is the most frequently diagnosed metastatic breast cancer (mBC) subtype. Combinations of endocrine therapy (ET) with cyclin-dependent kinase 4/6 inhibitors (CDK4 & 6is) improve outcome...